Clinical assessment of biomedical technology
- 1 March 1993
- journal article
- review article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 36 (3) , 301-307
- https://doi.org/10.1007/bf02053518
Abstract
The rapid expansion of new, unproven, and often expensive biomedical technology requires controlled clinical assessment before widespread diffusion into clinical practice. The accuracy, reliability, and validity all need to be assessed in an unbiased manner to determine whether implementation is of benefit to the clinician and patient. This article briefly describes the methodology available to determine whether new technologies such as diagnostic imaging techniques may be of benefit in clinical practice.Keywords
This publication has 22 references indexed in Scilit:
- The Clinical Efficacy of Diagnostic Imaging Evaluation StudiesInvestigative Radiology, 1991
- Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancersGastroenterology, 1989
- RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCERThe Lancet, 1989
- Repeated Screening for Colorectal Cancer with Fecal Occult Blood Test: A Prospective Randomized Study at Funen, DenmarkScandinavian Journal of Gastroenterology, 1989
- Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjectsCancer, 1988
- Assessment of radiologic tests: control of bias and other design considerations.Radiology, 1988
- Biases in the assessment of diagnostic testsStatistics in Medicine, 1987
- Carcinoembryonic AntigenAnnals of Internal Medicine, 1986
- Clinical biostatistics: LIV. The biostatistics of concordanceClinical Pharmacology & Therapeutics, 1981
- Clinical utility of CAT body scansThe American Journal of Surgery, 1978